What's new
US Message Board 🦅 Political Discussion Forum

Register a free account today to become a member! Once signed in, you'll be able to participate on this site by adding your own topics and posts, as well as connect with other members through your own private inbox!

Remdesivir is the greatest scandal of the pandemic

excalibur

Diamond Member
Joined
Mar 19, 2015
Messages
6,633
Reaction score
12,102
Points
2,290
And naturally, Fauci pushes it in spite of the studies showing its ineffectiveness and dangers.



Is there anything produced or approved by our government for COVID that isn't ineffective, doesn't have terrible side effects, and doesn't actually make the virus worse? The lockdowns, masks, and shots not only failed to work, but caused terrible collateral damage, failed to stop the virus, and, in fact, likely made the virus become more virulent. Now there are reports that remdesivir, which we already know doesn't work and causes renal and liver failure, might also be making the virus itself worse.

Antiviral agents, whether vaccine or therapeutic, must be perfect. If they fail to fully work, they can create viral immune escape, whereby the virus learns how to mutate around them. It's sort of like the principle of shooting at the king and missing, a principle we are often concerned with regarding the overuse or misuse of antibiotics.

Researchers from the Yale School of Medicine posted a preprint study in which they discovered a mutated version of SARS-CoV-2 that appears to have redeveloped in a previously infected immunocompromised woman who was treated with remdesivir. Researchers were able to sequence the genome in a way that made it clear it was related to the remdesivir use in the patient. The patient was later cured by monoclonal antibodies. "This case illustrates the importance of monitoring for remdesivir resistance and the potential benefit of combinatorial therapies in immunocompromised patients with SARS-CoV-2 infection," the study's authors wrote.

...

But it gets worse. On Dec. 12, 2019, less than five months before Fauci and the FDA pushed approval of remdesivir without consulting with an outside panel of experts, the New England Journal of Medicine published a study on remdesivir use in Ebola that should have gotten the drug permanently banned for any use. Over the preceding year, the researchers conducted a randomized controlled trial of four therapeutics for use against Ebola in the Democratic Republic of Congo: remdesivir and three types of monoclonal antibodies, including Regeneron. What were the results in Table 2 of the study?

Of the four drugs, remdesivir had the worst outcome with a 53.1% death rate, which is higher than the death rate from the virus. In fact, both remdesivir and ZMapp (death rate of 49.7%) were deemed to be so dangerous that they were pulled from the study on Aug. 9, 2019. Incidentally, Regeneron, which had the lowest death rate, is the monoclonal antibody therapy that seems to work well for COVID. Why would Fauci first pick remdesivir over Regeneron?

On April 29, Fauci announced that remdesivir would become the standard of care, and another study he cited was Gilead's own March 2020 study (eventually published in the NEJM in June) of 53 coronavirus patients in the U.S. Canada, Europe, and Japan who used remdesivir for 10 days. Sixty percent reported adverse events and 23% reported serious adverse events, the most common being "multiple-organ-dysfunction syndrome, septic shock, acute kidney injury, and hypotension." Furthermore, "Four patients (8%) discontinued remdesivir treatment prematurely: one because of worsening of preexisting renal failure, one because of multiple organ failure, and two because of elevated aminotransferases, including one patient with a maculopapular rash."

This is why the NIH to this day warns about renal failure and liver toxicity from the use of this drug that is bankrupting us and killing people in the hospitals. The WHO recommends against using it. The WHO's Solidarity trial, which was conducted on 2,750 patients in 405 hospitals across 30 countries, found "little or no effect of remdesivir on mortality," even though "the proportion of lower-risk patients happened to be appreciably greater in the remdesivir group than in the placebo group."

Last year, in France's Bichat-Claude Bernard University Hospital, researchers studied outcomes in the first five COVID ICU patients who were administered remdesivir. Researchers observed, "Remdesivir was interrupted before the initially planned duration in four patients, two because of alanine aminotransferase elevations (3 to 5 normal range) and two because of renal failure requiring renal replacement." Elevated alanine aminotransferase is usually an indication of liver toxicity, one of the warnings the NIH has given about the use of remdesivir.

...



 

sparky

Platinum Member
Joined
Oct 19, 2008
Messages
20,155
Reaction score
6,601
Points
350
Location
paradise

Turtlesoup

Diamond Member
Joined
Aug 10, 2020
Messages
12,905
Reaction score
13,831
Points
2,288
And naturally, Fauci pushes it in spite of the studies showing its ineffectiveness and dangers.


Is there anything produced or approved by our government for COVID that isn't ineffective, doesn't have terrible side effects, and doesn't actually make the virus worse? The lockdowns, masks, and shots not only failed to work, but caused terrible collateral damage, failed to stop the virus, and, in fact, likely made the virus become more virulent. Now there are reports that remdesivir, which we already know doesn't work and causes renal and liver failure, might also be making the virus itself worse.
Antiviral agents, whether vaccine or therapeutic, must be perfect. If they fail to fully work, they can create viral immune escape, whereby the virus learns how to mutate around them. It's sort of like the principle of shooting at the king and missing, a principle we are often concerned with regarding the overuse or misuse of antibiotics.
Researchers from the Yale School of Medicine posted a preprint study in which they discovered a mutated version of SARS-CoV-2 that appears to have redeveloped in a previously infected immunocompromised woman who was treated with remdesivir. Researchers were able to sequence the genome in a way that made it clear it was related to the remdesivir use in the patient. The patient was later cured by monoclonal antibodies. "This case illustrates the importance of monitoring for remdesivir resistance and the potential benefit of combinatorial therapies in immunocompromised patients with SARS-CoV-2 infection," the study's authors wrote.
...
But it gets worse. On Dec. 12, 2019, less than five months before Fauci and the FDA pushed approval of remdesivir without consulting with an outside panel of experts, the New England Journal of Medicine published a study on remdesivir use in Ebola that should have gotten the drug permanently banned for any use. Over the preceding year, the researchers conducted a randomized controlled trial of four therapeutics for use against Ebola in the Democratic Republic of Congo: remdesivir and three types of monoclonal antibodies, including Regeneron. What were the results in Table 2 of the study?
Of the four drugs, remdesivir had the worst outcome with a 53.1% death rate, which is higher than the death rate from the virus. In fact, both remdesivir and ZMapp (death rate of 49.7%) were deemed to be so dangerous that they were pulled from the study on Aug. 9, 2019. Incidentally, Regeneron, which had the lowest death rate, is the monoclonal antibody therapy that seems to work well for COVID. Why would Fauci first pick remdesivir over Regeneron?
On April 29, Fauci announced that remdesivir would become the standard of care, and another study he cited was Gilead's own March 2020 study (eventually published in the NEJM in June) of 53 coronavirus patients in the U.S. Canada, Europe, and Japan who used remdesivir for 10 days. Sixty percent reported adverse events and 23% reported serious adverse events, the most common being "multiple-organ-dysfunction syndrome, septic shock, acute kidney injury, and hypotension." Furthermore, "Four patients (8%) discontinued remdesivir treatment prematurely: one because of worsening of preexisting renal failure, one because of multiple organ failure, and two because of elevated aminotransferases, including one patient with a maculopapular rash."
This is why the NIH to this day warns about renal failure and liver toxicity from the use of this drug that is bankrupting us and killing people in the hospitals. The WHO recommends against using it. The WHO's Solidarity trial, which was conducted on 2,750 patients in 405 hospitals across 30 countries, found "little or no effect of remdesivir on mortality," even though "the proportion of lower-risk patients happened to be appreciably greater in the remdesivir group than in the placebo group."
Last year, in France's Bichat-Claude Bernard University Hospital, researchers studied outcomes in the first five COVID ICU patients who were administered remdesivir. Researchers observed, "Remdesivir was interrupted before the initially planned duration in four patients, two because of alanine aminotransferase elevations (3 to 5 normal range) and two because of renal failure requiring renal replacement." Elevated alanine aminotransferase is usually an indication of liver toxicity, one of the warnings the NIH has given about the use of remdesivir.
...



When my husband got Covid---he was put in the hospital twice. The first time for 3 days and the second for 10 days.
The first time, they gave him remdesivir and the antibodies for 3 (they claim 4 days but that isn't what my records or their records say) days even though you are supposed to get the antibodies for 5-10 days at one time a day. Needless to say, that this did not get rid of covid and he was put back in the hospital a few days later for the full 10 doses of the antibodies. The Remdesivir did not get rid of Covid.
 

Doc7505

Diamond Member
Joined
Feb 16, 2016
Messages
9,151
Reaction score
14,856
Points
2,430
Location
North Carolina
Meanwhile Ivermectin has treated nearly 300 million East Indians and has been proven a successful cheap and effective method of treating Covid-19 and it's variants.
The Quisling and complicit media has blocked this information from getting out. It does not fit their narrative.

**********​
**********​
 
Last edited:

eagle1462010

Diamond Member
Joined
May 17, 2013
Messages
53,624
Reaction score
20,776
Points
2,250
Meanwhile Ivermectin has treated nearly 300 million East Indians and has been proven a successful cheap and effective method of treating Covid-19 and it's variants.
The Quislong and complicit media has block this information from getting out. It does not fit their narrative.

**********​
**********​
India is suing the WHO over disinformation of their treatments. That work and are cheap.

4 times our population. a little over halve the number of deaths.
 

Fort Fun Indiana

Diamond Member
Joined
Mar 10, 2017
Messages
63,391
Reaction score
14,543
Points
2,220
Meanwhile Ivermectin has treated nearly 300 million East Indians and has been proven a successful cheap and effective method of treating Covid-19 and it's variants.
Shameless lie.
 

Fort Fun Indiana

Diamond Member
Joined
Mar 10, 2017
Messages
63,391
Reaction score
14,543
Points
2,220
India is suing the WHO over disinformation of their treatments. That work and are cheap.

4 times our population. a little over halve the number of deaths.
First of all, Ivermectin does not work.

Second, that death toll is totally bunk.


 

eagle1462010

Diamond Member
Joined
May 17, 2013
Messages
53,624
Reaction score
20,776
Points
2,250

Fort Fun Indiana

Diamond Member
Joined
Mar 10, 2017
Messages
63,391
Reaction score
14,543
Points
2,220
NPR is not the source, ya dipshit. This is just your excuse for being too lazy to read the article and too married to your talking point to possibly find out you are wrong. The WHO reports the numbers the Indian government gives them. So all you have done is to repeat your apparently inaccurate claim.
 

22lcidw

Platinum Member
Joined
Dec 25, 2018
Messages
25,500
Reaction score
9,931
Points
895
First of all, Ivermectin does not work.

Second, that death toll is totally bunk.


The real agenda is to tame the Western World. To reduce the wealth in real terms and make us more compliant. Western Prog women are the Devil's assistants in this insanity.
 

sparky

Platinum Member
Joined
Oct 19, 2008
Messages
20,155
Reaction score
6,601
Points
350
Location
paradise
Every other country in the world has a three-stage process for approving and pricing prescription drugs. Governments first ask if the drug is safe. If the answer is yes, it asks if the drug is effective.

If the drug passes those two hurdles, most governments then ask how much more effective the new drug is compared to existing medicines. This efficacy calculation becomes the starting point for price negotiations, which usually involve threatening to keep the drug out of the country’s state-insured pool of medications if the company does not come up with a reasonable price.

The U.S. either skips or botches these steps. First, there is no regulatory review that determines comparative efficacy. In the U.S., the FDA review ends after the first two steps: Once a drug is deemed safe and effective, it goes on the market.

~S~
 

USMB Server Goals

Total amount
$120.00
Goal
$350.00

Most reactions - Past 7 days

Forum List

Top